Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:300-311
© 2001 American Heart Association, Inc.
Brief Reviews |
Cytoskeletal Effects of Rho-Like Small Guanine Nucleotide–Binding Proteins in the Vascular System
From the Gaubius Laboratory TNO-PG (G.P.v.N.A., V.W.M.v.H.), Leiden, and the Department of Physiology, Institute for Cardiovascular Research (G.P.v.N.A., V.W.M.v.H.), Vrije Universiteit, Amsterdam, the Netherlands.
Correspondence to Prof Dr V.W.M. van Hinsbergh, Gaubius Laboratory TNO-PG, PO Box 2215, 2301 CE Leiden, Netherlands. E-mail VWM.VANHINSBERGH{at}PG.TNO.NL
Abstract—Rho-like small GTPases, with their main representatives (Rho, Rac, and Cdc42), have been recognized in the past decade as key regulators of the F-actin cytoskeleton. Rho-like small GTPases are now known to play a major role in vascular processes caused by changes in the actin cytoskeleton, such as smooth muscle cell contraction, endothelial permeability, platelet activation, and leukocyte migration. Data are now accumulating regarding the involvement of Rho GTPases in vascular disorders associated with vascular remodeling, altered cell contractility, and cell migration. The unraveling of signal transduction pathways used by the Rho-like GTPases revealed many upstream regulators and downstream effector molecules, and their number is still growing. An important action of Rho, Rac, and Cdc42 is their ability to regulate the phosphorylation status of the myosin light chain, a major regulator of actin-myosin interaction. Present knowledge of the Rho-like small GTPases has resulted in the development of promising new strategies for the treatment of many vascular disorders, including hypertension, vasospasms, and vascular leakage.
Key Words: small GTPases • vascular disorders
This article has been cited by other articles:
 |
|
 |
|
  V. A. de Jesus Perez, T.-P. Alastalo, J. C. Wu, J. D. Axelrod, J. P. Cooke, M. Amieva, and M. Rabinovitch Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-{beta}-catenin and Wnt-RhoA-Rac1 pathways J. Cell Biol., January 12, 2009; 184(1): 83 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wojciak-Stothard, B. Torondel, L. Zhao, T. Renne, and J. M. Leiper Modulation of Rac1 Activity by ADMA/DDAH Regulates Pulmonary Endothelial Barrier Function Mol. Biol. Cell, January 1, 2009; 20(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, T. Syrovets, S. Paskas, Y. Laumonnier, and T. Simmet Mature Dendritic Cells Express Functional Thrombin Receptors Triggering Chemotaxis and CCL18/Pulmonary and Activation-Regulated Chemokine Induction J. Immunol., July 15, 2008; 181(2): 1215 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Adamson, J. C. Ly, R. K. Sarai, J. F. Lenz, A. Altangerel, D. Drenckhahn, and F. E. Curry Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1188 - H1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Moustafa-Bayoumi, M. A. Alhaj, O. El-Sayed, S. Wisel, M. A. Chotani, Z. A. Abouelnaga, M. D. H. Hassona, K. Rigatto, M. Morris, G. Nuovo, et al. Vascular Hypertrophy and Hypertension Caused by Transgenic Overexpression of Profilin 1 J. Biol. Chem., December 28, 2007; 282(52): 37632 - 37639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Furman, A. L. Sieminski, A. V. Kwiatkowski, D. A. Rubinson, E. Vasile, R. T. Bronson, R. Fassler, and F. B. Gertler Ena/VASP is required for endothelial barrier function in vivo J. Cell Biol., November 19, 2007; 179(4): 761 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rivera, M. P. Ocaranza, S. Lavandero, and J. E. Jalil Rho Kinase Activation and Gene Expression Related to Vascular Remodeling in Normotensive Rats With High Angiotensin I Converting Enzyme Levels Hypertension, October 1, 2007; 50(4): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Schroder, I. Helmcke, K. Palfi, K.-H. Krause, R. Busse, and R. P. Brandes Nox1 Mediates Basic Fibroblast Growth Factor-Induced Migration of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1736 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gorovoy, R. Neamu, J. Niu, S. Vogel, D. Predescu, J. Miyoshi, Y. Takai, V. Kini, D. Mehta, A. B. Malik, et al. RhoGDI-1 Modulation of the Activity of Monomeric RhoGTPase RhoA Regulates Endothelial Barrier Function in Mouse Lungs Circ. Res., July 6, 2007; 101(1): 50 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Su, M. Hodnett, N. Wu, A. Atakilit, C. Kosinski, M. Godzich, X. Z. Huang, J. K. Kim, J. A. Frank, M. A. Matthay, et al. Integrin {alpha}vbeta5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier Function Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 377 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Isenberg, F. Hyodo, K.-I. Matsumoto, M. J. Romeo, M. Abu-Asab, M. Tsokos, P. Kuppusamy, D. A. Wink, M. C. Krishna, and D. D. Roberts Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation Blood, March 1, 2007; 109(5): 1945 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Guilluy, M. Rolli-Derkinderen, P.-L. Tharaux, G. Melino, P. Pacaud, and G. Loirand Transglutaminase-dependent RhoA Activation and Depletion by Serotonin in Vascular Smooth Muscle Cells J. Biol. Chem., February 2, 2007; 282(5): 2918 - 2928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tian and M. V. Autieri Cytokine expression and AIF-1-mediated activation of Rac2 in vascular smooth muscle cells: a role for Rac2 in VSMC activation Am J Physiol Cell Physiol, February 1, 2007; 292(2): C841 - C849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kanthou, S. Kranjc, G. Sersa, G. Tozer, A. Zupanic, and M. Cemazar The endothelial cytoskeleton as a target of electroporation-based therapies Mol. Cancer Ther., December 1, 2006; 5(12): 3145 - 3152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Goueffic, C. Guilluy, P. Guerin, P. Patra, P. Pacaud, and G. Loirand Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation Cardiovasc Res, November 1, 2006; 72(2): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. G. Versteilen, I. J. M. Korstjens, R. J. P. Musters, A. B. J. Groeneveld, and P. Sipkema Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney Am J Physiol Renal Physiol, September 1, 2006; 291(3): F606 - F611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Birukova, D. Adyshev, B. Gorshkov, G. M. Bokoch, K. G. Birukov, and A. D. Verin GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L540 - L548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shimokawa and A. Takeshita Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1767 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rolli-Derkinderen, V. Sauzeau, L. Boyer, E. Lemichez, C. Baron, D. Henrion, G. Loirand, and P. Pacaud Phosphorylation of Serine 188 Protects RhoA from Ubiquitin/Proteasome-Mediated Degradation in Vascular Smooth Muscle Cells Circ. Res., June 10, 2005; 96(11): 1152 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wojciak-Stothard, L. Y. F. Tsang, and S. G. Haworth Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L749 - L760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Loirand, M. Rolli-Derkinderen, and P. Pacaud RhoA and resistance artery remodeling Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1051 - H1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Clements, F. L. Minnear, H. A. Singer, R. S. Keller, and P. A. Vincent RhoA and Rho-kinase dependent and independent signals mediate TGF-{beta}-induced pulmonary endothelial cytoskeletal reorganization and permeability Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L294 - L306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, S. E. Kelemen, and M. V. Autieri Expression of granulocyte colony-stimulating factor is induced in injured rat carotid arteries and mediates vascular smooth muscle cell migration Am J Physiol Cell Physiol, January 1, 2005; 288(1): C81 - C88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hirayama, Y. Hata, Y. Noda, M. Miura, I. Yamanaka, H. Shimokawa, and T. Ishibashi The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3896 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Sylvester The tone of pulmonary smooth muscle: ROK and Rho music? Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L624 - L630. [Full Text] [PDF]
|
|
|
|
|
|
C. Boer, G. P. van Nieuw Amerongen, A. B. J. Groeneveld, G. J. Scheffer, J. J. de Lange, N. Westerhof, V. W. M. van Hinsbergh, and P. Sipkema Smooth muscle F-actin disassembly and RhoA/Rho-kinase signaling during endotoxin-induced alterations in pulmonary arterial compliance Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L649 - L655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, Y. J. Suzuki, R. M. Day, and B. L. Fanburg Rho Kinase-Induced Nuclear Translocation of ERK1/ERK2 in Smooth Muscle Cell Mitogenesis Caused by Serotonin Circ. Res., September 17, 2004; 95(6): 579 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hattori, H. Shimokawa, M. Higashi, J. Hiroki, Y. Mukai, H. Tsutsui, K. Kaibuchi, and A. Takeshita Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice Circulation, May 11, 2004; 109(18): 2234 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. van Nieuw Amerongen, K. Natarajan, G. Yin, R. J. Hoefen, M. Osawa, J. Haendeler, A.J. Ridley, K. Fujiwara, V. W.M. van Hinsbergh, and B. C. Berk GIT1 Mediates Thrombin Signaling in Endothelial Cells: Role in Turnover of RhoA-Type Focal Adhesions Circ. Res., April 30, 2004; 94(8): 1041 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Brantley-Sieders, J. Caughron, D. Hicks, A. Pozzi, J. C. Ruiz, and J. Chen EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation J. Cell Sci., April 15, 2004; 117(10): 2037 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hattori, H. Shimokawa, M. Higashi, J. Hiroki, Y. Mukai, K. Kaibuchi, and A. Takeshita Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice Circ. Res., January 9, 2004; 94(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Willis, D. Pierre-Paul, B. E. Sumpio, and V. Gahtan Vascular Smooth Muscle Cell Migration: Current Research and Clinical Implications Vascular and Endovascular Surgery, January 1, 2004; 38(1): 11 - 23. [Abstract] [PDF]
|
|
|
|
|
|
Y. Matsumoto, T. Uwatoku, K. Oi, K. Abe, T. Hattori, K. Morishige, Y. Eto, Y. Fukumoto, K.-i. Nakamura, Y. Shibata, et al. Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 181 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Feil, S. M. Lohmann, H. de Jonge, U. Walter, and F. Hofmann Cyclic GMP-Dependent Protein Kinases and the Cardiovascular System: Insights From Genetically Modified Mice Circ. Res., November 14, 2003; 93(10): 907 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Essler, S. Linder, B. Schell, K. Hufner, A. Wiedemann, K. Randhahn, J. M. Staddon, and M. Aepfelbacher Cytotoxic Necrotizing Factor 1 of Escherichia coli Stimulates Rho/Rho-Kinase-Dependent Myosin Light-Chain Phosphorylation without Inactivating Myosin Light-Chain Phosphatase in Endothelial Cells Infect. Immun., September 1, 2003; 71(9): 5188 - 5193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. GRATZINGER, S. CANOSA, B. ENGELHARDT, and J. A. MADRI Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho FASEB J, August 1, 2003; 17(11): 1458 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Holinstat, D. Mehta, T. Kozasa, R. D. Minshall, and A. B. Malik Protein Kinase C{alpha}-Induced p115RhoGEF Phosphorylation Signals Endothelial Cytoskeletal Rearrangement J. Biol. Chem., August 1, 2003; 278(31): 28793 - 28798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lin, A. C. Ceacareanu, and A. Hassid Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H710 - H721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Autieri, S. E. Kelemen, and K. W. Wendt AIF-1 Is an Actin-Polymerizing and Rac1-Activating Protein That Promotes Vascular Smooth Muscle Cell Migration Circ. Res., May 30, 2003; 92(10): 1107 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wojciak-Stothard and A. J. Ridley Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases J. Cell Biol., April 28, 2003; 161(2): 429 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Sauzeau, M. Rolli-Derkinderen, C. Marionneau, G. Loirand, and P. Pacaud RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase Activation J. Biol. Chem., March 7, 2003; 278(11): 9472 - 9480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Karbowniczek, J. Yu, and E. P. Henske Renal Angiomyolipomas from Patients with Sporadic Lymphangiomyomatosis Contain Both Neoplastic and Non-Neoplastic Vascular Structures Am. J. Pathol., February 1, 2003; 162(2): 491 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. van Nieuw Amerongen, P. Koolwijk, A. Versteilen, and V. W.M. van Hinsbergh Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 211 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tsukamoto, K.-i. Hirano, S. Yamashita, N. Sakai, C. Ikegami, Z. Zhang, F. Matsuura, H. Hiraoka, A. Matsuyama, M. Ishigami, et al. Retarded Intracellular Lipid Transport Associated With Reduced Expression of Cdc42, a Member of Rho-GTPases, in Human Aged Skin Fibroblasts: A Possible Function of Cdc42 in Mediating Intracellular Lipid Transport Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1899 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, T. Fukutomi, A. C. Zago, R. Ehlers, P. A. Detmers, S. D. Wright, C. Rogers, and D. I. Simon Simvastatin Reduces Neointimal Thickening in Low-Density Lipoprotein Receptor-Deficient Mice After Experimental Angioplasty Without Changing Plasma Lipids Circulation, July 2, 2002; 106(1): 20 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Shiojima and K. Walsh Role of Akt Signaling in Vascular Homeostasis and Angiogenesis Circ. Res., June 28, 2002; 90(12): 1243 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cicchetti, P. G. Allen, and M. Glogauer CHEMOTACTIC SIGNALING PATHWAYS IN NEUTROPHILS: FROM RECEPTOR TO ACTIN ASSEMBLY Critical Reviews in Oral Biology & Medicine, May 1, 2002; 13(3): 220 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Urbich, E. Dernbach, A. M. Zeiher, and S. Dimmeler Double-Edged Role of Statins in Angiogenesis Signaling Circ. Res., April 5, 2002; 90(6): 737 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kanthou and G. M. Tozer The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells Blood, March 15, 2002; 99(6): 2060 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Urbich, E. Dernbach, A. M. Zeiher, and S. Dimmeler Double-Edged Role of Statins in Angiogenesis Signaling Circ. Res., April 5, 2002; 90(6): 737 - 744. [Abstract] [Full Text] [PDF]
|
|